Chicago Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291K Buy
4,010
+10
+0.3% +$720 0.01% 324
2026
Q2
$283K Hold
4,000
– – 0.01% 326
2026
Q1
$209K Sell
4,000
-952
-19% -$57.1K 0.01% 346
2025
Q4
$291K Buy
4,952
+952
+24% +$57.8K 0.01% 309
2025
Q3
$223K Hold
4,000
– – 0.01% 338
2025
Q2
$206K Hold
4,000
– – 0.01% 343
2025
Q1
$235K Hold
4,000
– – 0.01% 312
2024
Q4
$288K Hold
4,000
– – 0.01% 278
2024
Q3
$320K Hold
4,000
– – 0.01% 258
2024
Q2
$287K Hold
4,000
– – 0.01% 268
2024
Q1
$282K Hold
4,000
– – 0.01% 259
2023
Q4
$309K Hold
4,000
– – 0.01% 235
2023
Q3
$272K Hold
4,000
– – 0.01% 195
2023
Q2
$327K Hold
4,000
– – 0.01% 188
2023
Q1
$297K Hold
4,000
– – 0.01% 193
2022
Q4
$332K Hold
4,000
– – 0.02% 184
2022
Q3
$284K Hold
4,000
– – 0.02% 199
2022
Q2
$347K Hold
4,000
– – 0.02% 191
2022
Q1
$433K Hold
4,000
– – 0.02% 188
2021
Q4
$517K Hold
4,000
– – 0.02% 181
2021
Q3
$485K Hold
4,000
– – 0.02% 179
2021
Q2
$450K Hold
4,000
– – 0.02% 187
2021
Q1
$382K Hold
4,000
– – 0.02% 195
2020
Q4
$318K Hold
4,000
– – 0.01% 199
2020
Q3
$248K Hold
4,000
– – 0.01% 208
2020
Q2
$264K Buy
+4,000
New +$240K 0.02% 195
2020
Q1
– Sell
-4,000
Closed -$220K – 220
2019
Q4
$220K Buy
+4,000
New +$210K 0.01% 204
2019
Q3
– Sell
-4,000
Closed -$208K – 227
2019
Q2
$208K Buy
+4,000
New +$202K 0.01% 215
2018
Q4
– Sell
-4,000
Closed -$204K – 220
2018
Q3
$204K Buy
+4,000
New +$177K 0.01% 217

Other funds holding TECH

Chicago Capital's TECH Position: Q3 2026 in Review

Chicago Capital increased its Bio-Techne (TECH) stake by 0.25% in Q3 2026, buying an estimated $720 and bringing the position to 4,010 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #324.

Chicago Capital first reported a position in TECH in Q3 2018 and has held it in 29 quarters since. The position peaked at $517K in Q4 2021. 141 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Chicago Capital held 4,010 shares of Bio-Techne worth $291K as of Q3 2026.
  • Chicago Capital bought 10 Bio-Techne shares in Q3 2026, an estimated $720.
  • Bio-Techne made up 0.01% of Chicago Capital's portfolio in Q3 2026, its #324 holding.
  • Chicago Capital first reported a position in Bio-Techne in Q3 2018 and has held it in 29 quarters since.
  • Chicago Capital's Bio-Techne position peaked at $517K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Chicago Capital's 13F filing for Q3 2026, filed 13 Oct 2026.